Dr. Maheswari Senthil, MD

Dr. Senthil practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Senthil's NPI, 1578721239, was assigned on May 29, 2008. Dr. Senthil graduated from Madurai Medical College in 1998. Dr. Senthil's California license number on file is A104024.

Dr. Senthil's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Senthil's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Senthil to 1 more other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Senthil practices, 2 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Senthil's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Senthil is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Senthil's licenses on file in 2 states: California and New Jersey.

Dmand AI lists colon removal among the conditions Dr. Senthil treats.

CMS data shows 44 Medicare services from Dr. Senthil across 2 procedure codes in 2024, all of them office visits, for 38 Medicare patients. Medicare paid $4,122 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 38 Medicare patients who saw Dr. Senthil in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Senthil's median patient age at 63, with 56% women.

In 2024, Dr. Senthil wrote 57 Medicare Part D claims for 13 patients. 95% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $31 in total drug cost. In 2021, CMS named 13 claims across 1 drug.

Dr. Senthil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Senthil as offering telehealth.

Dmand AI links 105 papers to Dr. Senthil, published from 2005 to 2025. 2023 was the busiest year, with 12. The most frequent topics are Peritoneal Neoplasms, Breast Neoplasms and Colorectal Neoplasms. Dr. Senthil has published most often in Ann Surg Oncol. Dr. Senthil's most frequent co-authors are Carlos A. Garberoglio, MD, Sharon S. Lum, MD and Matthew Jordan Selleck, DO.

Dmand AI links Dr. Senthil to 2 clinical trials. Conditions studied include Intestinal Obstruction, Stomach Neoplasms and Constipation.

CMS Open Payments shows 25 general payments to Dr. Senthil from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. GE Healthcare paid the most, $22,072.

Dmand AI lists 17 awards for Dr. Senthil, most recently Excellence in Education in 2019.

Dr. Senthil graduated from Madurai Medical College in 1998. Dr. Senthil is a member of ACS.

Dr. Senthil is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.